118 related articles for article (PubMed ID: 36897378)
1. Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia.
Aref S; El-Ghonemy M; Shimaa H; Darwish A; Abdelmabood S; Khaled N
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e334-e338. PubMed ID: 36897378
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
Studd JB; Yang M; Li Z; Vijayakrishnan J; Lu Y; Yeoh AE; Paulsson K; Houlston RS
Leukemia; 2019 Jan; 33(1):1-14. PubMed ID: 29977016
[TBL] [Abstract][Full Text] [Related]
3. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.
Wang C; Chen J; Sun H; Sun L; Liu Y
Ann Hematol; 2015 Feb; 94(2):181-5. PubMed ID: 25195121
[TBL] [Abstract][Full Text] [Related]
4. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
[TBL] [Abstract][Full Text] [Related]
5. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
[TBL] [Abstract][Full Text] [Related]
6. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
Bhandari P; Ahmad F; Mandava S; Das BR
Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
[TBL] [Abstract][Full Text] [Related]
7.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract][Full Text] [Related]
8. The CEBPE rs2239633 genetic polymorphism on susceptibility to childhood acute lymphoblastic leukemia: an updated meta-analysis.
Liu J; Weiling G; Xueqin L; Liang X; Linhong W; Zhongwen C
Environ Health Prev Med; 2021 Jan; 26(1):2. PubMed ID: 33397280
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
[TBL] [Abstract][Full Text] [Related]
11. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
[No Abstract] [Full Text] [Related]
12. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
[No Abstract] [Full Text] [Related]
13. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
[TBL] [Abstract][Full Text] [Related]
14. IKZF1 rs4132601 and rs11978267 Gene Polymorphisms and Acute Lymphoblastic Leukemia: Relation to Disease Susceptibility and Outcome.
Mosaad YM; El-Ziny MA; Darwish A; Al-Harrass M; Abdmabood S; Fawzy IM; Sherif DM; Yakoub MG; Abdeltawab H
J Pediatr Hematol Oncol; 2020 Oct; 42(7):420-428. PubMed ID: 32769565
[TBL] [Abstract][Full Text] [Related]
15. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.
Prasad RB; Hosking FJ; Vijayakrishnan J; Papaemmanuil E; Koehler R; Greaves M; Sheridan E; Gast A; Kinsey SE; Lightfoot T; Roman E; Taylor M; Pritchard-Jones K; Stanulla M; Schrappe M; Bartram CR; Houlston RS; Kumar R; Hemminki K
Blood; 2010 Mar; 115(9):1765-7. PubMed ID: 20042726
[TBL] [Abstract][Full Text] [Related]
16. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
[TBL] [Abstract][Full Text] [Related]
17. DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
Zhao XQ; Cao WJ; Yang HP; Yang XW; Tang P; Sun L; Gao X
Tumour Biol; 2016 Aug; 37(8):10393-402. PubMed ID: 26846104
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of ARID5B rs7089424 and rs10994982 are associated with B-lineage ALL susceptibility in Chinese pediatric population.
Tao R; Liu YJ; Liu LF; Li W; Zhao Y; Li HM; Yi XL; Zhao ZY
J Chin Med Assoc; 2019 Jul; 82(7):562-567. PubMed ID: 31274788
[TBL] [Abstract][Full Text] [Related]
19. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.
Ghavami A; Fathpour G; Amirghofran Z
Pathol Oncol Res; 2018 Jul; 24(3):653-662. PubMed ID: 28828696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
